Your Location:
Home >
Browse articles >
Optimization of Processing Technology of Atractylodis Macrocephalae Rhizoma Processed with Aurantii Fructus Immaturus and Analysis of Its HPLC Fingerprint
Updated:2024-01-04
    • Optimization of Processing Technology of Atractylodis Macrocephalae Rhizoma Processed with Aurantii Fructus Immaturus and Analysis of Its HPLC Fingerprint

    • WANG Fang , YU Huan , LI Feng-qin , ZHANG Shuai-jie , LIU Huai-wei , DAI Liang-min , LI Yan , YANG Ming
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 17, Pages: 6-13(2018)
    • DOI: 10.13422/j.cnki.syfjx.20181604     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

30

Views

64

Downloads

4

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Exploring Intervention Effect of Atractylodis Macrocephalae Rhizoma Processed with Aurantii Fructus Immaturus Juice on Slow-transit Constipation and Its "Microbiota-Metabolism" Synergistic Regulation Mechanism Based on Theory of "Spleen Governing Transportation and Transformation"
Aurantii Fructus Immaturus, Atractylodis Macrocephalae Rhizoma, and Their Combination Treat Colonic Motility Disorders in Rats with Slow Transit Constipation via PINK1/Parkin Signaling Pathway-mediated Mitophagy
Quality Control of Standard Decoction of Aurantii Fructus Immaturus
Key Issues and Research Ideas of Traditional Chinese Medicine Anti-aging Guided by Essence-Qi-spirit Theory of Qiluo Doctrine
Regulatory Pathways of Cell Apoptosis in Diabetic Kidney Disease and Intervention by Traditional Chinese Medicine: A Review

Related Author

LI Dan
LIU Xiaoxia
WANG Xiaofen
HE Zuxin
WEI Junnan
LIU Yanqing
GAO Yuxuan
LUO Ping

Related Institution

Sichuan Chuanjikang Pharmaceutical Co. Ltd.
Mass Spectrometry Diagnosis & Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi University of Chinese Medicine
Suzhou Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
The Third Affiliated Hospital of Henan University of Chinese Medicine
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences